首页 生命科学正文

anti Phosphoserine/threonine 磷酸化丝氨酸/苏氨酸抗体 PP2551 ECM Biosciences

RightAB商城订购

Anti-Phosphoserine/threonine Rabbit Polyclonal Antibody

品牌/厂商:ECM Biosciences

货号/目录号:22-PP2551

规格单位:100 uL

抗体来源:Rabbit 兔多克隆抗体

种属反应性:Hu, Rt, Ms

ECM Biosciences产品链接

资料背景简介

Phosphorylation of specific serine or threonine residues is an important post-translational modification for regulating the activity of most proteins. Stimulation of a variety of cell signaling pathways activates the receptor and non-receptor ser/thr kinases that mediate these protein modifications. Antibodies that can detect phosphoserine or phosphothreonine residues are excellent tools for characterizing changes in the post-translational state of a broad range of phosphorylated proteins. Immunoprecipitation of proteins of interest followed by detection of phosphoserine or phosphothreonine using anti-phosphoserine antibody is commonly used to correlate changes in phosphorylation state with alterations in protein activity.

参考文献

Hunter T.(1987) Cell. 50(6):823.

Krishna, R.G. & Wold, F. (1993) Adv Enzymol Rel Areas Mol Biol 67:265.

Yaffe, M.B. & Elia, A.E. (2001) Curr Opin Cell Biol 13, 131-8.

抗原

Anti-Phosphoserine/threonine was generated from a panel of phosphoserine and phosphothreonine-containing peptide immunogens designed from human protein sequences. All peptide sequences used are highly conserved in many species.

缓冲液和保存成分

Rabbit polyclonal, affinity-purified antibody is supplied in 100μl phosphate-buffered saline, 50% glycerol, 1 mg/ml BSA, and 0.05% sodium azide. Store at –20°C. Stable for 1 year.

免疫性和应用

This antibody was cross-adsorbed to unphosphorylated peptide then affinity purified using a mix of phosphoserine and phosphothreonine peptides (without carrier). The antibody detects many serine or threonine phosphorylated proteins by western blot, immunocytochemistry, and ELISA.

咨询和订购:

北京华泰昕生物医疗技术有限公司,Tel: 010-83131025, email: info@hypercyte.com


本文地址:anti Phosphoserine/threonine 磷酸化丝氨酸/苏氨酸抗体 PP2551 ECM Biosciences https://www.5zhi.org/post/44.html